Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Tolerance in Cow’s Milk Allergy in the Infant
This study is currently recruiting participants.
Study NCT00298376   Information provided by Hospices Civils de Lyon
First Received: March 1, 2006   Last Updated: April 26, 2007   History of Changes

March 1, 2006
April 26, 2007
March 2006
 
 
 
Complete list of historical versions of study NCT00298376 on ClinicalTrials.gov Archive Site
 
 
 
Oral Tolerance in Cow’s Milk Allergy in the Infant
Oral Tolerance in Cow’s Milk Allergy in the Infant: Role of CD4+CD25+ T Cells and Intestinal Microflora

This study aims to determine if there is a link between cow’s milk allergy in infants and regulatory T cells dysfunction that should be transient in infant acquiring oral tolerance after 12 month avoiding food and persistent in others.

Cow’s milk allergy is evaluated by basophils activation test, T cells activation test, specific humoral response (IgA, IgE, IgG) in allergic infants before and after 12 month avoiding food, before and after low dose milk exposure, before and after oral challenge.

Number and function of regulatory T cells and microflora composition are measured at the same time.

Allergic infants are compared to age matched control group.

 
 
Observational
Natural History, Longitudinal, Case Control, Prospective Study
Cow’s Milk Allergy
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
50
 
 

Inclusion Criteria:

male or female, age before 6 month, cow’s milk allergy with positive prick or patch test for cow’s milk

Control group: male or female, age before 6 month or within 12 and 18 month, eating cow’s milk every day

Exclusion Criteria:

immunodeficiency syndrome, lactose intolerance Control group: other food allergy, atopic dermatitis.

Both
1 Month to 15 Months
Yes
Contact: Florence VILLARD-TRUC, MD 33 472 110 390 fvillardtruc@hotmail.com
Contact: Dominique KAISERLIAN, PhD kaiserlian@cervi-lyon.inserm.fr
France
 
NCT00298376
 
2005.389
Hospices Civils de Lyon
 
Principal Investigator: Alain LACHAUX, MD Hospices Civils de Lyon
Hospices Civils de Lyon
April 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP